Patients News | pharmaphorum

News

NHS hospitals 'should resist Palantir software rollout'

Hospitals in England have been told they do not have to deploy a controversial Palantir data platform by a coalition led by healthcare charity Medact.

News

Poll finds Americans cutting back elsewhere to fund health

Many Americans are forced to make difficult trade-offs with living expenses and delay life events like retirement to afford health, says a new poll.

News

Novo rapped by FDA for not reporting drug adverse effects

Novo Nordisk has been sent a warning letter from the FDA for violations of postmarketing adverse drug experience (PADE) regulations.

News

NHS cleared to use Astellas' non-hormonal menopause drug

Around half a million women will soon be able to access Astellas' Veoza treatment for symptoms like hot flushes associated with menopause.

News

Veeva buys brand engagement firm Ostro for $100m

Veeva Systems has reached a $100m deal to acquire Ostro, which helps pharma connect with doctors and patients using AI-based conversational tools.

News

Multicoloured letters with AUTISM spelled in the middle

FDA approves leucovorin – but not for autism

The FDA stops short of approving leucovorin for autism, but will its clearance for ultra-rare condition CFD-FOLR1 lead to more off-label prescribing?

NHS hospitals 'should resist Palantir software rollout'

Poll finds Americans cutting back elsewhere to fund health

Novo rapped by FDA for not reporting drug adverse effects

NHS cleared to use Astellas' non-hormonal menopause drug

Veeva buys brand engagement firm Ostro for $100m

FDA approves leucovorin – but not for autism

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks